Steve Shadowen is regularly recognized as a top national antitrust lawyer, a result of his dedicated work on cases where intellectual property and antitrust law intersect. Shadowen was lead counsel for the purchaser plaintiffs in the landmark litigation that began calling Big Pharma to account for anticompetitive conduct. Abbott Labs. v. Teva Pharmaceuticals, U.S.A., Inc.: Shadowen was on plaintiffs' trial team, and was one of the driving forces in the litigation, in the first case to accept the "product hopping" theory of anticompetitive conduct. Steve Shadowen consistently garners recognition as a Best Lawyer in America for Antitrust and Commercial Litigation and as a Pennsylvania SuperLawyer. He serves on the advisory boards of the American Antitrust Institute and the Institute for Consumer Antitrust Studies and is an adjunct professor at the Pennsylvania State University Dickinson School of Law. Shadowen has published numerous papers on antitrust and civil rights issues and lectured on antitrust and competition law at universities across the nation and in Europe. He is a committed advocate for equal access to education, serving on the board of the Harrisburg Public Schools Foundation and as a trustee of St. Edward’s University. Shadowen is also the President of the Joshua Group, an at-risk youth advocate organization. Prior to starting Hilliard Shadowen LLC, Shadowen was a partner at the Philadelphia-based firms, Hangley Aronchick Segal & Pudlin, and Schnader Harrison Segal & Lewis, where he represented plaintiffs in antitrust litigation for more than 19 years. As a law student he was the criminal procedure project editor of the Georgetown Law Journal. Upon graduation from Georgetown he served as a clerk for the Hon. Boyce F. Martin, Jr. of the United States Court of Appeals for the Sixth Circuit.